Clinica Colsanitas S.A. sede Clinica Universitaria Colombia

Bogota, D.C. 111321

1 studies enrolling now · 1 studies all time

What they study most

Moderately to Severely Active Crohns Disease

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now